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Abstract
Streptomyces species and other Actinobacteria are ubiquitous in diverse environments worldwide and are the source of, or
inspiration for, the majority of antibiotics. The genomic era has enhanced biosynthetic understanding of these valuable
chemical entities and has also provided a window into the diversity and distribution of natural product biosynthetic gene
clusters. Antimycin is an inhibitor of mitochondrial cytochrome c reductase and more recently was shown to inhibit Bcl-2/
Bcl-XL-related anti-apoptotic proteins commonly overproduced by cancerous cells. Here we identify 73 putative antimycin
biosynthetic gene clusters (BGCs) in publicly available genome sequences of Actinobacteria and classify them based on the
presence or absence of cluster-situated genes antP and antQ, which encode a kynureninase and a phosphopantetheinyl
transferase (PPTase), respectively. The majority of BGCs possess either both antP and antQ (L-form) or neither (S-form),
while a minority of them lack either antP or antQ (IQ- or IP-form, respectively). We also evaluate the biogeographical
distribution and phylogenetic relationships of antimycin producers and BGCs. We show that antimycin BGCs occur on five of
the seven continents and are frequently isolated from plants and other higher organisms. We also provide evidence for two
distinct phylogenetic clades of antimycin producers and gene clusters, which delineate S-form from L- and I-form BGCs.
Finally, our findings suggest that the ancestral antimycin producer harboured an L-form gene cluster which was primarily
propagated by vertical transmission and subsequently diversified into S-, IQ- and IP-form biosynthetic pathways.
INTRODUCTION
Microbial natural products, particularly those produced by
filamentous Actinobacteria, have been a cornerstone of the
pharmaceutical industry for more than half a century [1].
The genes encoding natural product biosynthesis are typi-
cally grouped together into a gene cluster, which possibly
enhances their transmissibility and the evolution of chemi-
cal diversity [2]. Little is understood about the forces driving
these processes, but access to large datasets of genome
sequences provides an opportunity for exploration.
Antimycin-type depsipeptides are a large and diverse family of
natural products widely produced by Streptomyces species [3].
The family’s namesake, the nine-membered ringed antimy-
cins, were discovered more than 65 years ago [4]. Ring-
extended members of this family have also been identified and
include: JBIR-06 (12-membered ring), neoantimycin (15-
membered ring) and respirantin (18-membered ring) [5–7].
All of these compounds possess antifungal, insecticidal and
nematocidal activity, as a result of their ability to inhibit mito-
chondrial cytochrome c reductase via a conserved 3-formami-
dosalicylate moiety [8]. Antimycins are used commercially as
a fish biocide, but were recently found to be potent and selec-
tive inhibitors of the mitochondrial Bcl2/Bcl-xL-related anti-
apoptotic proteins, which are over-produced by cancer cells
and confer resistance to apoptotic chemotherapeutic agents
[9]. To date, the biosynthesis of antimycins has been reported
for a myriad of environmental isolates, but it was not until
recently that the hybrid non-ribosomal peptide synthetase
(NRPS)/polyketide synthase (PKS) biosynthetic pathway that
directs their assembly was revealed in a strain of Streptomyces
albus [10].
The ~25 kb antimycin biosynthetic gene cluster (BGC) har-
boured by S. albus is composed of 15 genes organized into
four polycistronic operons, antAB, antCDE, antFG and
antHIJKLMNO (Fig. 1) [11]. The biosynthetic gene cluster
was recently used as the basis for the reconstitution of antimy-
cin biosynthesis in vitro [12, 13] and heterologous production
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using Escherichia coli [14] and S. coelicolor [15]. The biosyn-
thesis and activation of the unusual starter unit, 3-formamido-
salicylate, is specified by the genes antFGHIJKLNO [12, 14,
16]. The di-modular NRPS, AntC and the unimodular PKS,
AntD comprise the NRPS-PKS assembly line, while AntE and
AntM are crotonyl-CoA carboxylase/reductase and discrete
ketoreductase enzymes, respectively, and AntB is an acyltrans-
ferase responsible for the acyloxyl moiety and the chemical
diversity observed at R1 (Fig. 1) [13]. The expression of the
antimycin BGC is coordinately regulated with the candicidin
BGC by a LuxR-family regulator, FscRI, which activates
expression of antABCDE [15]. The antA gene encodes a clus-
ter-situated extracytoplasmic function RNA polymerase sigma
(s) factor named sAntA, which activates transcription of the
antGF and antHIJKLMNO operons [11].
Intriguingly, subsequent identification of antimycin biosyn-
thetic pathways in other taxa revealed that the BGC pos-
sesses up to four architectures [17]: short-form (S-form, 15
genes), intermediate-form (IQ- or IP-form, 16 genes) and
long-form (L-form, 17 genes), based on the absence (S-
form) or presence (L-form) of two cluster-situated genes,
antP and antQ, which encode a kynureninase and phospho-
pantetheinyl transferase, respectively. I-form BGCs harbour
either antP (IP) or antQ (IQ), but not both (Fig. 1). How the
antimycin BGC evolved into these various architectures is
an intriguing question and one that we sought to address
with this study.
Here we identify 73 antimycin BGCs (five known and 68
putative) in publicly available genome sequences of Actino-
bacteria and evaluate their biogeographical distribution and
phylogenetic relationships. Isolation metadata suggest that
the antimycin BGC has a large biogeographical range, with
isolation of putative antimycin producers from at least five
continents. Our phylogenetic analyses support the existence
of two distinct clades of antimycin producers and BGCs
which delineate S-form from L- and I-form BGCs. Finally,
our findings suggest that the ancestral antimycin producer
harboured an L-form BGC that was primarily propagated
by vertical transmission and subsequently diversified into
S-, IQ- and IP-form biosynthetic pathways.
METHODS
Identification of putative antimycin biosynthetic
gene clusters
The genomes available in GenBank on 9 May 2017 for select
genera of Actinobacteria (Actinobactera, Actinomadura,
Actinospica, Amycolatopsis, Kitasatospora,Micromonospora,
Nocardia, Saccharopolyspora, Planomonospora, Pseudono-
cardia, Salinispora, Streptacidiphilus and Streptomyces) were
downloaded using the ncbi-genome-download python
Fig. 1. Schematic representation of L-, IQ-, IP- and S-form antimycin biosynthetic gene clusters. AT, acyltransferase; NRPS, non-ribo-
somal peptide synthetase; PKS, polyketide synthase; CCR, crotonyl-CoA carboxylase/reductase; PPTase, phosphopantetheinyl transfer-
ase. Antimycins: Antimycin A1, R
1=COCH(CH3)CH2CH3, R
2=(CH2)4CH3; Antimycin A2, R
1=COCH(CH3)2, R
2=(CH2)4CH3; Antimycin A3, R
1
=COCH2CH(CH3)2, R
2=(CH2)2CH3; Antimycin A4, R
1=COCH(CH3)2, R
2=(CH2)2CH3.
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script provided by Kai Blin available at https://github.com/
kblin/ncbi-genome-download. One thousand four hundred
and twenty-one genomes were downloaded in total and
were subsequently annotated using Prokka 1.12 [18]. Next,
annotated GenBank files were modified using the Unix
commands grep and sed to move the unique gene prefix
generated by Prokka from the ‘/locus_tag’ field to the ‘/gene’
field. A multigeneblast database was created using the
makedb programme of multigeneblast version 1.1.13 and
the processed GenBank files from above [19]. The genes
antFGHIJKLMNOPQ of the antimycin BGC from S. ambo-
faciens ATCC 23877 [16] were used as a multigeneblast
query with the default settings. The resulting output was
inspected manually to identify genomes harbouring a puta-
tive antimycin BGC. PROmer [20] and the S. ambofaciens
antimycin BGC were used to identify contigs comprising
antimycin BGCs split across more than one contig. This
applied to the following taxa: S. gancidicus BKS 13–15, S. sp.
B9173, S. sp. CC71, S. sp. HNS054, S. sp. IgraMP-1, S. sp.
MBT28, S. sp. NRRL B-24085, S. sp. TOR3209 and S. sp.
SM8. S. wadayamensis strain A23, which harbours a puta-
tive S-form antimycin BGC, was discarded because it lacked
multiple phylosift markers (see below).
Phylogenetic analyses
In order to infer a species phylogeny, 29 single-copy phylo-
genetic markers (13 061 nt in total) were identified
and extracted using Phylosift version 1.0.1 (Tables S1) [21]
and concatenated in the order: DNGNGWU00002,
DNGNGWU00003, DNGNGWU00007, DNGNGWU00009,
DNGNGWU00010, DNGNGWU00011, DNGNGWU00012,
DNGNGWU00014, DNGNGWU00015, DNGNGWU00016,
DNGNGWU00017, DNGNGWU00018, DNGNGWU00019,
DNGNGWU00021, DNGNGWU00022, DNGNGWU00023,
DNGNGWU00024, DNGNGWU00025, DNGNGWU00026,
DNGNGWU00027, DNGNGWU00028, DNGNGWU00029,
DNGNGWU00030, DNGNGWU00031, DNGNGWU00033,
DNGNGWU00034, DNGNGWU00036, DNGNGWU00037,
DNGNGWU00040. The concatenated phylogenetic marker
sequences were aligned using 16 iterations of MUSCLE [22] and
the. fasta format alignment was converted to sequential phylip
format using Geneious R8.1.19. Phylogenetic relationships
were inferred from this alignment using the web-implementa-
tion of PhyML3.0 available at www.atgc-montpellier.fr/phyml/
[23].
In order to infer a phylogeny for putative antimycin BGCs,
10 genes (antFGHIJKLMNO) were extracted and aligned
using MUSCLE. The resulting alignment was imported into
Geneious R8.1.19 and manually trimmed to the same length
prior to concatenating sequences in the following gene
order: antFGHIJKLMNO. The concatenated alignment was
then converted to sequential phylip format and a phyloge-
netic tree was inferred using PhyML3.0 as above.
Likelihood analysis
Reconstruction of the ancestral state was performed essen-
tially as described previously [24]. Briefly, the trace
character function of Mesquite v3.2 [25] was used to infer
the ancestral node for the antimycin BGC within the species
tree. A categorical character matrix for BGC type was cre-
ated and likelihood calculations were performed using the
Mk1 model.
RESULTS AND DISCUSSION
Identification of putative antimycin biosynthetic
gene clusters (BGCs) in Actinobacteria
Established and putative antimycin BGCs were previously
identified within the genomes of 14 Streptomyces species
[17, 26]. However, casual analyses of the genome sequences
available in GenBank suggested that this number is likely to
be far greater. In order to formally assess this possibility,
1421 publically available genome sequences for select Acti-
nobacteria genera (i.e. those with a history of natural
products production: (Actinobactera, Actinomadura, Acti-
nospica, Amycolatopsis, Kitasatospora, Micromonospora,
Nocardia, Saccharopolyspora, Planomonospora, Pseudono-
cardia, Salinispora, Streptacidiphilus and Streptomyces) were
downloaded and annotated using Prokka 1.12 [18]. The
Prokka annotation enabled the construction of a customized
mutligeneblast database, which was subsequently used in
conjunction with the antFGHIJKLMNOPQ genes from S.
ambofaciens and multigeneblast 1.1.13 [19] to generate a list
of taxa harbouring a putative antimycin BGC. The genes
antFGHIJKLMNO were selected on the basis that they are
essential for antimycin biosynthesis and are conserved in all
established antimycin BGCs; antPQ were also included in
order to permit the tentative classification of gene cluster
architecture (see below). Close inspection of gene clusters
from the candidate list resulted in the identification of an
antimycin BGC in 73 taxa (five known and 68 putative)
(Table 1). Among these, five are described as non-Strepto-
myces species: Saccharopolyspora flava DSM 44771, Strepta-
cidiphilus albus JL83, Streptacidiphilus albus NBRC 100918,
Actinospica acidiphila NRRL B-24431 and Actinobacteria
bacterium OV320 (Table 1).
Inspection of loci identified as encoding 3-formamidosalicy-
late biosynthetic genes revealed a few noteworthy peculiari-
ties. Streptomyces albus subsp. albus strain NRRL B-2513
possesses a clear 3-formamidosalicylate locus, but lacks
antM and the core NRPS-PKS biosynthetic machinery at
this locus or elsewhere in the genome; and Streptomyces
phaeoluteigriseus strain DSM 41896 has endured at least
two frameshift mutations in antD, which presumably render
it non-functional. In addition, Streptomyces lincolnensis
strain NRRL 2936, Streptomyces sp. yr375 and Streptomyces
sp. ERV7 each harbour the same antimycin-like BGC. How-
ever, gene rearrangement and insertion is evident: for exam-
ple, a small locus of fatty acid anabolism genes has been
inserted between the 3-formamidosalicylate biosynthetic
genes and the NRPS-PKS machinery, suggesting that the
biosynthetic pathway may not in fact produce antimycins.
These strains and BGCs were discarded as a consequence of
these peculiarities.
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Table 1. Actinobacteria harbouring a putative antimycin biosynthetic gene cluster (BGC)
Organism Source Genome accession Antimycin BGC
form*
S IP IQ L
Actinobacteria bacterium OV320 Populus trichocarpa, Corvallis, Oregon, USA LJCX00000000.1
Actinospica acidiphilaNRRL B-24431 Soil, Gerenzano, Italy JNYX00000000.1
Saccharopolyspora flava DSM 44771 – FOZX00000000.1
Streptacidiphilus albus JL83 Soil, Co. Durham, UK JQML00000000.1
Streptacidiphilus albus NBRC 100918 – BBPL00000000.1
Streptomyces albidoflavus NRRL B-1271 – JOII00000000.1
Streptomyces albidoflavus OsiLf-2 Rice, Changsha, Hunan, China MNPQ00000000.1
Streptomyces albidoflavus R-53649 – FWFA00000000.1
Streptomyces albus J1074† – CP004370.1
Streptomyces albus S4† Acromyrmex octospinosus, Trinidad CADY00000000.1
Streptomyces albus SM254 Soil, Soudan, Minnesota, USA CP014485.1
Streptomyces ambofaciens ATCC 23877† Soil, Picardie, France CP012382.1
Streptomyces ambofaciens DSM 40697 Soil, Rome, Italy CP012949.1
Streptomyces antibioticus DSM 41481 Soil, USA CM007717.1
Streptomyces caelestis NRRL B-24567 – LGCN00000000.1
Streptomyces gancidicus BKS 13–15 Soil, Odisha, India AOHP00000000.1
Streptomyces griseoflavus Tu4000 – ACFA00000000.1
Streptomyces griseorubens strain JSD-1 Soil, Shanghai, China JJMG00000000.1
Streptomyces griseus subsp. griseus NRRL B-
2307
– JNZI00000000.1
Streptomyces griseus subsp. griseus NRRL F-
5618
– JOGU00000000.1
Streptomyces griseus subsp. griseus NRRL F-
5621
– JOGN00000000.1
Streptomyces griseus subsp. griseus NRRL
WC-3066
– LLZL00000000.1
Streptomyces hygroscopicus subsp.
jinggangensis 5008
– CP003275.1
Streptomyces hygroscopicus subsp.
jinggangensis TL01
– CP003720.1
Streptomyces longwoodensis DSM 41677 – LMWS00000000.1
Streptomyces sp. M10 Marine sediment, Dalian, China AMZL00000000.1
Streptomyces mirabilis OV308 – JQJV00000000.1
Streptomyces pluripotens MUSC 135 Mangrove, Malaysia JTDH00000000.1
Streptomyces pluripotens MUSC 137 Mangrove, Malaysia JUIF00000000.2
Streptomyces radiopugnans CGMCC 4.3519 – FOET00000000.1
Streptomyces sampsonii KJ40 Poplar tree rhizosphere, Ya’an, Sichuan, China CP016824.1
Streptomyces sp. 303MFCol5.2 – ARTR00000000.1
Streptomyces sp. 4F Soil, Shanghai, China CP013142.1
Streptomyces sp. Amel2xC10 – FWZW00000000.1
Streptomyces sp. AVP053U2 Marine sediment, Avery Point, Connecticut, USA LMTQ00000000.2
Streptomyces sp. B9173 Ocean sediment, Germany NAVC00000000.1
Streptomyces sp. BvitLS-983 – FMCF00000000.1
Streptomyces sp. CC71 Sediment from Churince hydrological system, Cuatro, Cienegas,
Coahuila, Mexico
LOSR00000000.1
Streptomyces sp. CdTB01 Soil, Changsha, China CP013743.1
Streptomyces sp. CNQ431† Marine sediment, La Jolla, California, USA JTCK00000000.1
Streptomyces sp. CNY228 – ARIN00000000.1
Streptomyces sp. F-7 – FKJH00000000.1
Streptomyces sp. FR-008 – CP009802.1
Streptomyces sp. GBA 94–10 Phakellia ventilabrum, Trondheimfjord, Norway CM002271.1
Streptomyces sp. HNS054 Unknown sponge, Fujian, China LDZX00000000.1
Streptomyces sp. IgraMP-1 – FMCM00000000.1
Streptomyces sp. JHA26 Soil, Japan BDJC00000000.1
Streptomyces sp. KE1 Human skin, New Delhi, India‡ LAYX00000000.1
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Classification of antimycin BGCs
Antimycin BGCs exist in four architectures, and the gene
clusters identified here were classified as short-form (S-
form, 15 genes), intermediate-form (IP- or IQ-form, 16
genes) and long-form (L-form, 17 genes), based on the
absence (S-form) or presence (L-form) of two cluster-situ-
ated genes: antP, which encodes a kynureninase (InterPro
ID, IPR010111) involved in the production of the 3-forma-
midosalicylate starter unit, and antQ, which is a phospho-
pantetheinyl transferase (InterPro ID, IPR0082788)
responsible for the post-translational modification of the
NRPS/PKS assembly line to its pantetheinylated form [17].
The organization of the genes within antimycin BGCs
shows 100% synteny (Fig. 1), and their functions are
described in Table 2. Annotation of the putative biosyn-
thetic pathways identified above resulted in the classifica-
tion of 25 S-form, 13 IP-form, five IQ-form and 30 L-form
antimycin BGCs (Table 1).
The first step in the biosynthesis of the 3-formamidosalicy-
late starter unit is oxygenation of the indole ring of
tryptophan by the AntN tryptophan 2,3-dioxygenase,
resulting in kynurenine. This is then presumably converted
to anthranilate by the AntP kynureninase (harboured by L-
and IP-forms), whereas in the S- and IQ-forms this function-
ality is provided by the housekeeping kynureninase involved
in normal tryptophan catabolism [17]. AntF then activates
anthranilate, which is subsequently loaded onto the AntG
carrier protein. An important point is that although the L-
and IP-forms possess AntP and thus have a ‘dedicated’
source of anthranilate, all variants of the antimycin biosyn-
thetic pathway are able to access anthranilate from the ‘core’
anthranilate pool within the cell, which is corroborated by
feeding studies with exogenous fluoroanthranilates [16].
The maintenance of antP by L- and IP-forms and its loss by
S- and IQ-forms may be driven by physiological differences,
for instance the availability of cytosolic anthranilate. It is
perhaps not surprising that AntQ is not essential in the S-
and IP-forms; in fact, most NRPS and PKS biosynthetic sys-
tems lack a cluster-situated PPTase and are dependent on
the promiscuity of one or more PPTase enzymes encoded
elsewhere in the genome. This is clearly the case for S- and
Table 1. cont.
Organism Source Genome accession Antimycin BGC
form*
S IP IQ L
Streptomyces sp. LaPpAH-202 Petalomyrmex phylax plant-ants, Cameroon ARDM00000000.1
Streptomyces sp. MBT28 Soil, Lanzarote, Canary Islands, Spain LARV00000000.1
Streptomyces sp. MUSC 125 Mangrove, Malaysia JUIG00000000.1
Streptomyces sp. NBRC 110035 – BBNN00000000.1
Streptomyces sp. NBRC 110468 – BBYG00000000.1
Streptomyces sp. NRRL B-24085 Peanut, South Africa LJBR00000000.1
Streptomyces sp. NRRL B-2790 – JOHI00000000.1
Streptomyces sp. NRRL B-3253 – JOGQ00000000.1
Streptomyces sp. NRRL F-2305 – JOFW00000000.1
Streptomyces sp. NRRL F-4835 – JOIEL00000000.1
Streptomyces sp. NRRL F-5008 Farm feed lot waste, Norris Farms, Dickson Mounds, Illinois, USA JOHW00000000.1
Streptomyces sp. NRRL F-5527 Tobacco, unknown location‡ JOHL00000000.1
Streptomyces sp. NRRL S-1314 – JOHU00000000.1
Streptomyces sp. NRRL S-37 Soil, El Salvador JOIZ00000000.1
Streptomyces sp. PVA 94–07 Phakellia ventilabrum, Trondheimfjord, Norway CM002273.1
Streptomyces sp. Root1310 Arabidopsis thaliana root, Cologne, Germany LMEQ00000000.1
Streptomyces sp. Root1319 Arabidopsis thaliana root, Cologne, Germany LMEU00000000.1
Streptomyces sp. Root55 Arabidopsis thaliana root, Cologne, Germany LMFT00000000.1
Streptomyces sp. ScaeMP-6W – FMBX00000000.1
Streptomyces sp. SM8† Sponge, Galway, Ireland AMPN00000000.1
Streptomyces sp. SolWspMP-5a-2 – FMCI00000000.1
Streptomyces sp. TOR3209 Tomato rhizosophere, unknown location‡ AGNH00000000.1
Streptomyces sp. URHA0041 Mediterranean grassland soil JNIH00000000.1
Streptomyces sp. XY152 Soil, Urbana, Illinois, USA LGDQ00000000.1
Streptomyces yokosukanensis DSM 40224 Soil, Yokosuka City, Japan LMWN00000000.1
*See Fig. 1 and manuscript text for definitions of S-, IP-, IQ- and L-form BGCs.
†Antimycin production verified experimentally.
‡Location not mapped in Fig. 2.
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IP-form antimycin BGCs, but it may not be so for L-form
antimycin BGCs, as antimycin production was abolished in
an S. ambofaciens DantQ mutant [27]. The contextual
requirement of antP and antQ for antimycin biosynthesis
creates the opportunity for divergent evolution of the anti-
mycin BGC.
Biogeographical distribution of antimycin
biosynthesis
The biogeography of natural products biosynthesis is an
emerging area and one that can not only guide future natu-
ral products bioprospecting campaigns, but which enables
formulation of interesting questions in chemical microbial
ecology [24, 28]. Thus, we curated isolation metadata for
putative antimycin producers to ascertain any patterns in
source material or its geographical origin. The breadth of
data varied considerably, but a source and/or country loca-
tion was available in GenBank or within the literature for
38 out of 73 strains (Table 1). Sample collection data were
plotted onto a world map and pins were colour-coded
based on gene cluster architecture. Inspection of the result-
ing map did not show an obvious link between gene cluster
architecture and geographical location, but did reveal that
putative antimycin producers have been isolated from a rel-
atively large geographical area, including at least five of the
seven continents: Africa, Asia, Europe, North America and
South America (Fig. 2). Only a single strain originates from
the southern hemisphere, which is surprising; however, this
is likely a consequence of the inherent limitations of the
dataset. Like geographical location, gene cluster architecture
and isolation source material do not appear to be related,
however, but as anticipated, many strains originate from
various soil ecosystems (17 in total) or marine sediments
(four in total), which supports the long-standing view that
these niches are rich sources of bioactive metabolites.
Interestingly, 18 of the strains were isolated from plants,
sponges or insects, suggesting that they may be involved in
symbioses, which is in line with the increasing number of
reports implicating antibiotic-producing strains as defen-
sive symbionts of higher organisms [29, 30]. Overall, these
data suggest that antimycin-producing Actinobacteria are
likely distributed worldwide, which may reflect the signifi-
cance of producing an inhibitor of eukaryotic cytochrome c
reductase in diverse niches.
Distribution of antimycin BGCs within Actinobacteria
The collection of putative antimycin BGCs identified here
provides an opportunity to further explore their phyloge-
netic and evolutionary relationships. A multi-locus phylog-
eny was reconstructed in order to evaluate the taxonomic
distribution of antimycin BGCs. Phylosift was used to iden-
tify and extract phylogenetic markers from the genome of
each microbe described in Table 1. This resulted in the iden-
tification of 29 phylogenetic markers present in single copy
in each taxon (see Table S1, available in the online Supple-
mentary Material for description of markers). The markers
were concatenated, aligned (length 13 119 nt) and used to
infer a maximum likelihood (ML) phylogenetic tree (Fig. 3).
Inspection of the resulting phylogeny suggested that six
strains have been taxonomically mis-assigned. For instance,
Actinospica acidiphila strain NRRL B-24431 and Actinobac-
teria bacterium strain OV320 group closely with Streptomy-
ces species placed within the interior of the tree, and are
therefore likely to be members of the genus Streptomyces
(Fig. 3). Additionally, four taxa designated as S. griseus (S.
griseus subsp. griseus NRRL B-2307, S. griseus subsp. griseus
NRRL F-5618, S. griseus subsp. griseus NRRL F-5621, S. gri-
seus subsp. griseus NRRL WC-3066) group within the S.
albus J1074 clade and are thus likely strains of this species
and not strains of the streptomycin producer, S. griseus.
Next, the phylogenetic tree was colour-coded based on the
gene cluster architectures determined above. The sixth
bifurcation divides the tree into two major clades, one of
which contains 24 of the 25 strains harbouring an S-form
antimycin BGC (Clade I), and a second that contains strains
harbouring exclusively IP-, IQ- and L- form antimycin BGCs
(Clade II, Fig. 3). Within Clade I, all 24 S-form strains are
closely related to S. albus J1074. Within Clade II, 50% of the
L-form antimycin BGCs are harboured by taxa that com-
prise a single subclade near the top of the tree that includes
several isolates from the United States Department of Agri-
culture NRRL collection, as well as A. acidiphila NRRL B-
24431 (Fig. 3). The remaining L-form antimycin BGCs are
harboured by small groupings of strains as well as single-
tons, and interspersed amongst L-form taxa are those that
harbour IQ- and IP-form gene clusters (Fig. 3). Interestingly,
seven strains fall outside of Clades I and II: S. sp.
URHA0041 (S-form), S. radiopugnans CGMCC 4.3519 (IQ-
form), S. flava DSM 44771 (IP-form), and S. sp. Root1319,
S. sp. Root55, S. albus JL83 and S. albus NRBC 100918 (all
L-form), which suggests that either these strains may be
closely related to the ancestral antimycin producer or the
Table 2. Functions of proteins encoded by antimycin BGCs
Protein Function
AntA Extracytoplasmic function RNA polymerase sigma factor
AntB Acyltransferase
AntC Dimodular non-ribosomal peptide synthetase
AntD Unimodular polyketide synthase
AntE Crotonyl-CoA reductase/decarboxylase
AntF Acyl-CoA ligase
AntG Peptidyl carrier protein
AntH Multi-component oxygenase
AntI Multi-component oxygenase
AntJ Multi-component oxygenase
AntK Multi-component oxygenase
AntL Multi-component oxygenase
AntM Ketoreductase
AntN Tryptophan 2,3-dioxygenase
AntO N-formylase
AntP Kynureninase
AntQ Phosphopantetheinyl transferase
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genes for antimycin biosynthesis were horizontally acquired
by these strains (Fig. 3).
Antimycin BGC phylogeny
A ML phylogeny was inferred from concatenated sequences
of antFGHIJKLMNO (alignment length 9736 nt) and col-
our-coded based on gene cluster architecture as above, in
order to evaluate the evolutionary relationships of antimy-
cin BGCs. These genes were selected because they are con-
served in all BGCs and changes to their DNA sequence
should not impact antimycin biochemical diversity. The
third bifurcation divides the tree into two major clades,
Clade I which harbours only S-form antimycin BGCs and
Clade II which harbours exclusively L-, IQ- and IP-form
antimycin BGCs (Fig. 4). As with the phylosift phylogeny
above, 24 of the 25 S-form antimycin BGCs comprise a
closely related clade, which was anticipated after the revela-
tion that all of these BGCs are harboured by strains closely
related to S. albus J1074 (Fig. 4). L-form antimycin BGCs
appear throughout Clade II; 14 of the 30 L-forms clade
together at the top of the tree and the majority of the
remainder comprise smaller groupings consisting of five,
three and two members with two singletons. Four of the five
IQ-form BGCs clade together and are flanked on either side
by L-form antimycin BGCs. IP-form antimycin BGCs form
two clades in the centre of the tree comprising a total of 12
of the 13 gene clusters. Overall, the tree highlights that
phylogenetic placement of antimycin BGCs is linked to their
gene cluster architecture in the majority of cases. There are
three notable exceptions to this – S. albus JL83, S. albus
NBRC 100918 and S. sp. URHA0041 do not group into
either Clade I or II and their basal position within the phy-
logeny may suggest a close relationship with the ancestral
antimycin BGC (Fig. 4).
Antimycin BGC evolution
There are obvious similarities between the species and BGC
trees. For instance, both trees bifurcate to separate S-form
from IQ-, IP- and L-form taxa and BGCs. This, combined
with the presence of gene cluster architecture subclades in
both trees, suggests that speciation has been the primary
driver for dissemination of the antimycin BGC. With
respect to the both the species and BGC trees, it is reason-
able to propose that antimycin biosynthesis evolved once
and that the ancestral antimycin producer harboured an L-
form BGC. To test this hypothesis, a likelihood analysis was
used to predict the ancestral node for each architecture of
the antimycin BGC based on its distribution within the phy-
losift phylogeny. As expected, the likelihood analysis pre-
dicted that the ancestral antimycin producer harboured an
L-form BGC (Fig. 5). This supports a model in which loss of
antP and/or antQ, rather than their frequent independent
acquisition, resulted in diversification of gene cluster archi-
tecture. The ancestral antimycin producer likely gave rise to
Fig. 2. Geographical distribution of 38 Actinobacteria harbouring a putative antimycin biosynthetic gene cluster. Map pins are colour-
coded based on gene cluster classification. The map is available here: https://drive.google.com/open?id=
1rXUFJXSt8szUYMuCJExQbEP4X1k.
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Fig. 3. Maximum likelihood phylogeny of 73 Actinobacteria analysed in this study. The phylogeny is based on 29 concatenated ribo-
somal protein DNA sequences. SH-like support values are indicated at nodes as decimal values. Colours indicate gene cluster classifi-
cation. The scale bar represents 5% sequence divergence.
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S. albus JL83, S. albus NBRC 100918 and S. sp. URHA0041,
but S. sp. URHA0041 lost antP and antQ after speciation.
The same ancestral L-form strain presumably also seeded
Clade I where antP and antQ were lost in the process, but
were retained during the genesis of Clade II. One major
diversification event likely occurred to give rise to most of
the IP-form antimycin BGCs, but a second diversification
event appears to have occurred where antQ was lost by the
ancestor of S. sp. NRRL B-2790, S. pluripotens MUSC 135,
S. pluripotens MUSC137 and S. sp. MUSC125, but was
retained by the two S. hygroscopicus strains with which the
aforementioned clade. Finally, four of the five IQ-form
BGCs are derived from the L-form ancestor of S. ambofa-
ciens ATCC 23877 and S. ambofaciens DSM 40697.
Although the phylosift and BGC trees are consistent with
that proposed above, there is noticeable discordance
between the two phylogenies. The most profound of these
are highlighted below. Three closely related strains, S. ganci-
dicus, S. sp. NRRL S-1314 and S. sp. NRRL F-5527, group
within the large subclade of L-form BGCs in Clade II of the
phylosift tree, but shift to occupy a distantly related lineage
in Clade II of the antFGHIJKLMNO phylogeny. This
Fig. 4. Maximum likelihood phylogeny of the 73 antimycin biosynthetic gene clusters analysed in this study. The phylogeny is based
on concatenated antFGHIJKLMNO DNA sequences. SH-like support values are indicated at nodes as decimal values. Colours indicate
gene cluster classification. The scale bar represents 5% sequence divergence.
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suggests that the parent of the S. gancidicus subclade likely
received its L-form gene cluster by horizontal gene transfer.
The same is also likely true for S. sp. NRRL B-24085, which
is located within the centre of Clade II in the phylosift tree,
but then joins the large L-form subclade of Clade II in the
BGC tree. Interestingly, Sacharropolyspora flava DSM
Fig. 5. Likelihood analysis of ancestral antimycin BGC architectures. Filled circles are colour-coded to represent the proportional like-
lihood of BGC architecture at ancestral nodes within the species phylogeny depicted based on the ribosomal protein DNA sequences in
Fig. 3.
Fig. 6. Proposed evolutionary path of the antimycin BGC. The ancestral antimycin producer likely harboured an L-form gene cluster
which independently lost either antP, antQ or both of these genes to give rise to the IQ-, IP- and S-form gene clusters, respectively.
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44771, which is an ‘outlier’ in the phylosift tree (i.e. does not
group within Clade I or II), becomes part of Clade II in the
BGC tree and shares an ancestral node with the three-mem-
bered S. gancidicus subclade described above. This suggests
that S. flava and the S. gancidicus subclade likely received
their antimycin BGC from the same or a closely related
ancestor, and is consistent with the hypothesis that S. flava
originally harboured an L-form BGC, but independently lost
antQ to give rise to its IP-form BGC. In addition, three other
outliers from the phylosift tree group within Clade II of the
BGC tree: S. sp. Root1319, S. sp. Root55 and S. radiopu-
gnans, which suggests that their antimycin BGC was hori-
zontally acquired and moreover that S. radiopugnans
probably independently evolved an IQ-form antimycin BGC
from the clade founder.
Conclusions and perspectives
In this study, 73 antimycin BGCs were identified in the
genome sequences of Actinobacteria deposited in GenBank.
The isolation data for these strains indicate that antimycin-
producing actinomycetes are likely globally distributed,
highlighting a potentially important role for inhibiting cyto-
chrome c reductase in diverse ecological niches. The major-
ity of the antimycin BGCs identified contained both the
antP kynureninase and the antQ PPTase (L-form), or nei-
ther of these (S-form), while a minority of the gene clusters
lacked either the antP or antQ (IQ- or IP-form, respectively).
Phylogenetic analyses revealed two distinct lineages separat-
ing S-form from L-, IQ- and IP-form strains and BGCs, and
although a handful of taxa appear to have acquired the anti-
mycin BGC via horizontal gene transfer, the primary means
for dissemination of the gene cluster is vertical transmission.
The contextual requirement of antP and antQ presumably
permitted divergent evolution of the antimycin biosynthetic
pathway. We propose that the ancestral antimycin producer
harboured an L-form antimycin BGC, which spawned two
main clades, one composed of S-forms that lack both antP
and antQ, and one composed of L-forms with distinct sub-
clades of IP- and IQ-forms (Fig. 6).
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